Drug intelligence / Profile preview

PhtE_pep40

Development stage: Unknown
Modality: Peptides
Administration: Subcutaneous

Overview

PhtE_pep40 is a peptide derived from the zinc-binding domain of the pneumococcal histidine triad protein E (PhtE). It is used in the development of epitope-based vaccines against *Streptococcus pneumoniae*, demonstrating immunogenicity and protective effects by eliciting high IgG titers and facilitating antibody-mediated killing of pneumococci[3][5].

Beyond the preview

Go deeper on PhtE_pep40.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PhtE_pep40.

Explore the full profile